Princeton, NJ, United States of America

Mahender Reddy Karla

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahender Reddy Karla. Retrieved from https://idiyas.com/inventor/mahender-reddy-karla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mahender Reddy Karla: Innovator in JAK Inhibitor Development

Introduction

Mahender Reddy Karla is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors. His work has implications for various therapeutic areas, showcasing his expertise and innovative spirit.

Latest Patents

Mahender Reddy Karla holds a patent for a "Process for preparing enantiomerically enriched JAK inhibitors." This patent discloses improved processes and intermediates for preparing ruxolitinib and deuterated analogs of ruxolitinib. His innovative approach enhances the efficiency and effectiveness of these important pharmaceutical compounds.

Career Highlights

Karla is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role at Sun Pharmaceutical allows him to leverage his skills in drug development and contribute to the advancement of medical science.

Collaborations

Throughout his career, Mahender Reddy Karla has collaborated with esteemed colleagues, including Robert S Lewis and Kathryn E Kavouris. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mahender Reddy Karla's contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors, highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…